RCT- randomized control trial, SGLT2- sodium-glucose co-transporter 2, EVL- everolimus, TAC- tacrolimus, CYC- cyclosporine, NODAT- new-onset diabetes after transplantation, GFR-glomerular filtration rate, PTDM- post-transplantation diabetes mellitus, DPP4- dipeptidyl peptidase-4, GLP-1- glucagon-like peptide, LDL- low-density lipoprotein, CSII- continuous subcutaneous insulin lispro infusion, HbA1C- glycosylated hemoglobin. This evidence concerns the gene GCG and diabetes mellitus.